Physician profile
Caroline Hunt
NPI 1639837248
$340.57
in general payments reported to CMS, 2019-2025
11 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.35 · 2023: $51.64 · 2024: $91.60 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $63.31 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $50.03 | 2023-2024 | Pediarix, Bexsero |
| Sanofi-Aventis U.S. LLC | $36.50 | 2025 | |
| Pfizer INC. | $36.35 | 2023-2025 | |
| Cranial Technologies, INC | $32.87 | 2024-2025 | Doc Band |
| Sanofi Pasteur INC. | $26.63 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $24.97 | 2024 | Imcivree |
| Verrica Pharmaceuticals INC. | $21.16 | 2024 | Ycanth |
| Seqirus USA INC | $19.36 | 2025 | Flucelvax |
| Cipher Pharmaceuticals US LLC | $15.49 | 2025 | Natroba, Spinosad |
| Novo Nordisk INC | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.